BamSEC and AlphaSense Join Forces
Learn More

Neurocrine Biosciences Inc.

NASDAQ: NBIX    
Share price (12/20/24): $135.42    
Market cap (12/20/24): $13.7 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 10-K 4 pages Neurocrine Biosciences, Inc. and U.S. Bank National Association, as Trustee First Supplemental Indenture Dated as of December 20, 2021 2.25% Convertible Senior Notes Due 2024
12/34/56
EX-4.4
from 10-K 2 pages Description of Common Stock
12/34/56
EX-4.1
from 8-K 100 pages Neurocrine Biosciences, Inc. and U.S. Bank National Association as Trustee Indenture Dated as of May 2, 2017 2.25% Convertible Senior Notes Due 2024
12/34/56
EX-4.7
from S-3ASR 22 pages Neurocrine Biosciences, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of [ ], 20 Neurocrine Biosciences, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.6
from S-3ASR 24 pages Neurocrine Biosciences, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of [ ], 20 Neurocrine Biosciences, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.5
from S-3ASR 23 pages Neurocrine Biosciences, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of [ ], 20 Neurocrine Biosciences, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.2
from S-3ASR 53 pages Neurocrine Biosciences, Inc., Issuer and [Trustee], Trustee Indenture Dated as of , 20 Debt Securities
12/34/56
EX-4.2
from S-8 16 pages Neurocrine Biosciences, Inc. 2003 Incentive Stock Plan as Amended May 25, 2005, November 7, 2005 and January 12, 2006
12/34/56
EX-4.3
from S-8 ~20 pages Indenture or similar
12/34/56
EX-4.2
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4
from S-8 ~20 pages 2003 Incentive Stock Plan
12/34/56
EX-4
from S-8 ~5 pages Neurocrine Biosciences, Inc. 2001 Stock Option Plan as Amended August 6, 2002 and October 15, 2002
12/34/56
EX-4
from 10-Q ~5 pages Neurocrine Biosciences, Inc. 2001 Stock Option Plan as Amended August 6, 2002 and October 15, 2002
12/34/56
EX-4
from 10-Q ~5 pages Neurocrine Biosciences, Inc. 2001 Stock Option Plan
12/34/56
EX-4
from S-8 ~5 pages Neurocrine Biosciences, Inc. 1996 Director Option Plan
12/34/56
EX-4
from S-8 ~10 pages Neurocrine Biosciences, Inc. 1996 Employee Stock Purchase Plan
12/34/56
EX-4
from S-8 ~10 pages Neurocrine Biosciences, Inc. 1992 Incentive Stock Plan
12/34/56
EX-4
from 8-K ~50 pages Amended and Restated Preferred Shares Rights Agmt
12/34/56
EX-4
from S-3 >50 pages Form of Indenture
12/34/56
EX-4
from S-8 ~10 pages Indenture or similar
12/34/56